723 related articles for article (PubMed ID: 20304584)
1. Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial.
Depalma RG; Hayes VW; Chow BK; Shamayeva G; May PE; Zacharski LR
J Vasc Surg; 2010 Jun; 51(6):1498-503. PubMed ID: 20304584
[TBL] [Abstract][Full Text] [Related]
2. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial.
Zacharski LR; Chow BK; Howes PS; Shamayeva G; Baron JA; Dalman RL; Malenka DJ; Ozaki CK; Lavori PW
J Natl Cancer Inst; 2008 Jul; 100(14):996-1002. PubMed ID: 18612130
[TBL] [Abstract][Full Text] [Related]
3. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial.
Zacharski LR; Chow BK; Howes PS; Shamayeva G; Baron JA; Dalman RL; Malenka DJ; Ozaki CK; Lavori PW
JAMA; 2007 Feb; 297(6):603-10. PubMed ID: 17299195
[TBL] [Abstract][Full Text] [Related]
4. Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: the Iron (Fe) and Atherosclerosis Study (FeAST).
Zacharski LR; Chow BK; Howes PS; Lavori PW; Shamayeva G
Am Heart J; 2004 Sep; 148(3):386-92. PubMed ID: 15389223
[TBL] [Abstract][Full Text] [Related]
5. Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease.
Zacharski LR; Shamayeva G; Chow BK
Am Heart J; 2011 Nov; 162(5):949-957.e1. PubMed ID: 22093213
[TBL] [Abstract][Full Text] [Related]
6. Statins and biomarkers in claudicants with peripheral arterial disease: cross-sectional study.
DePalma RG; Hayes VW; May PE; Cafferata HT; Mohammadpour HA; Brigg LA; Chow BK; Shamayeva G; Zacharski LR
Vascular; 2006; 14(4):193-200. PubMed ID: 17026909
[TBL] [Abstract][Full Text] [Related]
7. Cytokine signatures in atherosclerotic claudicants.
DePalma RG; Hayes VW; Cafferata HT; Mohammadpour HA; Chow BK; Zacharski LR; Hall MR
J Surg Res; 2003 May; 111(2):215-21. PubMed ID: 12850465
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
[TBL] [Abstract][Full Text] [Related]
9. Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.
Sola S; Mir MQ; Rajagopalan S; Helmy T; Tandon N; Khan BV
J Card Fail; 2005 Oct; 11(8):607-12. PubMed ID: 16230264
[TBL] [Abstract][Full Text] [Related]
10. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
Beckman JA; Preis O; Ridker PM; Gerhard-Herman M
Am J Cardiol; 2005 Nov; 96(10):1374-8. PubMed ID: 16275181
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory markers and the risk of coronary heart disease in men and women.
Pai JK; Pischon T; Ma J; Manson JE; Hankinson SE; Joshipura K; Curhan GC; Rifai N; Cannuscio CC; Stampfer MJ; Rimm EB
N Engl J Med; 2004 Dec; 351(25):2599-610. PubMed ID: 15602020
[TBL] [Abstract][Full Text] [Related]
13. The role of biomarkers and genetics in peripheral arterial disease.
McDermott MM; Lloyd-Jones DM
J Am Coll Cardiol; 2009 Sep; 54(14):1228-37. PubMed ID: 19778662
[TBL] [Abstract][Full Text] [Related]
14. Preoperative statin treatment reduces systemic inflammatory response and myocardial damage in cardiac surgery.
Martínez-Comendador JM; Alvarez JR; Mosquera I; Sierra J; Adrio B; Carro JG; Fernández A; Bengochea J
Eur J Cardiothorac Surg; 2009 Dec; 36(6):998-1005. PubMed ID: 19581104
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and anaemia in a broad spectrum of patients with heart failure.
Kleijn L; Belonje AM; Voors AA; De Boer RA; Jaarsma T; Ghosh S; Kim J; Hillege HL; Van Gilst WH; van Veldhuisen DJ; van der Meer P
Heart; 2012 Aug; 98(16):1237-41. PubMed ID: 22730482
[TBL] [Abstract][Full Text] [Related]
16. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
17. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
Dosh K; Berger PB; Marso S; van Lente F; Brennan DM; Charnigo R; Topol EJ; Steinhubl S
Circ Cardiovasc Interv; 2009 Dec; 2(6):503-12. PubMed ID: 20031767
[TBL] [Abstract][Full Text] [Related]
18. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
19. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
McMurray JJ; Kjekshus J; Gullestad L; Dunselman P; Hjalmarson A; Wedel H; Lindberg M; Waagstein F; Grande P; Hradec J; Kamenský G; Korewicki J; Kuusi T; Mach F; Ranjith N; Wikstrand J;
Circulation; 2009 Dec; 120(22):2188-96. PubMed ID: 19917888
[TBL] [Abstract][Full Text] [Related]
20. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease.
Feringa HH; Karagiannis SE; van Waning VH; Boersma E; Schouten O; Bax JJ; Poldermans D
J Vasc Surg; 2007 May; 45(5):936-43. PubMed ID: 17360142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
